NATIONAL KIDNEY FOUNDATION for NATIONAL KIDNEY FOUNDATION

Health Issues HCR

Initiatives to increase and facilitate organ donation and transplantation, including the Living Donor Protection Act (S. 511 / H.R. 1224); the National Living Donor Assistance Center; increased utilization of Kidney Discards Activities in support of HHS Advancing American Kidney Health initiative Early detection and management of Chronic Kidney Disease Department of Health and Human Services Million Hearts initiative Department of Health and Human Services KidneyX initiative Prescription Drug Pricing and Access Healthy People 2030 Management of the Patient Protection and Affordable Care Act Reauthorization of the Patient-Centered Outcomes Research Institute Repeal and Replacement of the Affordable Care Act

Contacted: Natl Institutes of Health (NIH); Health Resources & Services Administration (HRSA); Health & Human Services, Dept of (HHS); Centers For Medicare and Medicaid Services (CMS); SENATE; Centers For Disease Control & Prevention (CDC); HOUSE OF REPRESENTATIVES; Food & Drug Administration (FDA)

Bills named: H.R. 1224 (116th), S. 511 (116th)

Budget/Appropriations BUD

FY 2020 Appropriations for the Department of Health and Human Services (NIH, CDC, HRSA); Food and Drug Administration; Indian Health Service, Veterans Affairs, and Department of Defense

Contacted: Natl Institutes of Health (NIH); Centers For Disease Control & Prevention (CDC); Centers For Medicare and Medicaid Services (CMS); Health & Human Services, Dept of (HHS); Food & Drug Administration (FDA); SENATE; HOUSE OF REPRESENTATIVES; Health Resources & Services Administration (HRSA)

Medicare/Medicaid MMM

Early detection and management of Chronic Kidney Disease, including Alternative Payment Model Increased utilization of home dialysis Extension of Medicare coverage of immunosuppressive drugs for kidney transplant recipients Increased use of Kidney Discards for transplantation Access of medications under Medicare Part D Protected Classes Comments on proposed rule on ESRD Treatment Choices Model Comments on ESRD Prospective Payment System and Quality Incentive Program Comments on interpretive guidance Conditions of Participation for organ transplant programs Comments on proposed revisions for organ procurement organization Conditions of Coverage outcomes measures

Contacted: Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES; Centers For Disease Control & Prevention (CDC); Centers For Medicare and Medicaid Services (CMS); SENATE; Health Resources & Services Administration (HRSA); Natl Institutes of Health (NIH); Food & Drug Administration (FDA)